Orexo AB OTC Stock Top Insiders

ORXOF Stock  USD 1.08  0.00  0.00%   
Orexo AB employs about 126 people. The company is managed by 9 executives with a total tenure of roughly 46 years, averaging almost 5.0 years of service per executive, having 14.0 employees per reported executive. Examination of Orexo AB's management performance can provide insight into the company performance.
Nikolaj Sorensen  CEO
Pres CEO
Robert DeLuca  President
President of Orexo US Inc.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orexo AB. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons.

Orexo AB Management Team Effectiveness

The company has return on total asset (ROA) of (0.0965) % which means that it has lost $0.0965 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6535) %, meaning that it generated substantial loss on money invested by shareholders. Orexo AB's management efficiency ratios could be used to measure how well Orexo AB manages its routine affairs as well as how well it operates its assets and liabilities.

Orexo AB Workforce Comparison

Orexo AB is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 45,660. Orexo AB adds roughly 126 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Orexo AB Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Orexo AB Price Series Summation is a cross summation of Orexo AB price series and its benchmark/peer.

Orexo AB Notable Stakeholders

An Orexo AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orexo AB often face trade-offs trying to please all of them. Orexo AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orexo AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Nikolaj SorensenPres CEOProfile
Robert DeLucaPresident of Orexo US Inc.Profile
Fredrik JarrstenEx CFOProfile
MD MBAChief OfficerProfile
Cecilia CouplandVP OperationsProfile
Lena WangeInvestor Relations & Communications ManagerProfile
Jesper LindAdvisorProfile
Dennis UrbaniakEx TherapeuticsProfile
Robert RonnVP RDProfile

About Orexo AB Management Performance

The success or failure of an entity such as Orexo AB often depends on how effective the management is. Orexo AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orexo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orexo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.
The data published in Orexo AB's official financial statements typically reflect Orexo AB's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Orexo AB's quantitative information. For example, before you start analyzing numbers published by Orexo accountants, it's essential to understand Orexo AB's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

Orexo AB Workforce Analysis

Traditionally, organizations such as Orexo AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orexo AB within its industry.

Orexo AB Manpower Efficiency

Return on Orexo AB Manpower

Revenue Per Employee4.5M
Revenue Per Executive62.8M
Net Loss Per Employee1.8M
Net Loss Per Executive24.8M
Working Capital Per Employee4.8M
Working Capital Per Executive67.1M

Complementary Tools for Orexo OTC Stock analysis

When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk